Have Privia Health Group, Inc. (NASDAQ:PRVA) Insiders Been Selling Their Stock?

We wouldn't blame Privia Health Group, Inc. (NASDAQ:PRVA) shareholders if they were a little worried about the fact that Jeffrey Bernsteinn, the Independent Director recently netted about US$69m selling shares at an average price of US$27.69. However, it's crucial to note that they remain very much invested in the stock and that sale only reduced their holding by 8.0%.

Check out our latest analysis for Privia Health Group

Privia Health Group Insider Transactions Over The Last Year

In fact, the recent sale by Jeffrey Bernsteinn was the biggest sale of Privia Health Group shares made by an insider individual in the last twelve months, according to our records. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. The silver lining is that this sell-down took place above the latest price (US$23.71). So it is hard to draw any strong conclusion from it.

Insiders in Privia Health Group didn't buy any shares in the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Does Privia Health Group Boast High Insider Ownership?

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. I reckon it's a good sign if insiders own a significant number of shares in the company. Privia Health Group insiders own 11% of the company, currently worth about US$273m based on the recent share price. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

What Might The Insider Transactions At Privia Health Group Tell Us?

Insiders haven't bought Privia Health Group stock in the last three months, but there was some selling. And even if we look at the last year, we didn't see any purchases. The company boasts high insider ownership, but we're a little hesitant, given the history of share sales. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Privia Health Group. While conducting our analysis, we found that Privia Health Group has 2 warning signs and it would be unwise to ignore these.

Of course Privia Health Group may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.